LTHOUGH the mechanism of motor disturbances in PD is not fully understood, a functional schema has been proposed for the regulation of motor activities ( Fig. 1 ; modified from DeLong 7 ). According to this schema, dopaminergic neurons in the substantia nigra pars compacta act on the striatal GABAergic neurons consisting of two subpopulations with distinct dopamine receptors, one dominated by D 1 receptors (D 1 neurons) and the other by D 2 receptors (D 2 neurons). The D 1 neurons are directly connected to the GPi (direct striatopallidal pathway), whereas the D 2 neurons have an indirect connection with the GPi and the SNr through the GABAergic neurons in the globus pallidus externus and the glutamatergic neurons in the STN (indirect striatopallidal pathway). On stimulation with dopamine, the D 1 neurons exert an inhibitory effect on the release of GABA from the GPi and SNr, whereas the D 2 neurons facilitate GABA release from the GPi and SNr through an indirect action on glutamatergic neurons in the STN connected to the GPi and SNr.
amelioration of akinesia with dopaminergic drugs is associated with an increase in the activity of abnormally depressed supplementary motor and premotor cortices, 13 ,21 the areas involved in the initiation of movements. 13 From this observation we infer that dopamine reduces the excessive inhibitory outflow from neurons in the basal ganglia. Indeed, a high firing rate in the GPi in patients with PD diminishes after administration of a potent D 1 and D 2 dopamine receptor agonist, apomorphine, in doses that reverse parkinsonism. 21 Apparently, this schema is not complete. The thalamotomy, with its consequent diminution of thalamic activation of the cortex, should worsen PD, and the pallidotomy at GPi, by diminishing inhibitory outflow from the basal ganglia, should produce hemiballism, as occurs with spontaneous lesions in the STN. Neither of these predictions has been borne out by surgical experience. These inaccurate predictions of surgical response may reflect the fact that the schema considers only neuronal discharge rates rather than the more complex neuronal firing patterns, potentially more important neuromodulation through dopamine D 1 and D 2 receptors, or the fact that the circuit may behave in a manner different from that expected in the chronic dopaminedeficient state.
In this study we have assessed the effect of PVP or DBS of the GPi on the D 2 receptor binding potential by using PET scanning with 11 C-nemonapride, and we have also correlated the clinical outcome of the surgical treatment with alterations in the D 2 receptor binding potential. Nemonapride is a selective D 2 antagonist that is being used in PET studies to assess the postsynaptic D 2 receptor function in experimental animals [15] [16] [17] 19 and humans. 3, 20, 22, 32, [42] [43] [44] [45] 47 Clinical Material and Methods
Patient Population
Stereotactic pallidal surgery was performed in six patients with advanced PD (three men and three women). The mean age of the patients was 56.2 Ϯ 9.8 years and the average duration of symptoms was 16.8 Ϯ 10.4 years. The patients with rigidity-akinesia dominant symptoms, severely fluctuating response to levodopa, and dopa-induced dyskinesia were selected because PVP or DBS of the GPi has been effective for such cases. 30 These patients received either DBS of the GPi or PVP: one on the right side, four on the left, and one bilaterally. Before and after the operation, the severity of symptoms in the on and off states was assessed by identifying the Hoehn and Yahr stage, 18 the UPDRS 10 score, and the Schwab and England score. 41 Clinical features of these patients are summarized in Table 1 .
Eight healthy male volunteers with a mean age of 59.5 Ϯ 8.1 years were recruited after obtaining written informed consent in accordance with the guidelines approved by Tohoku University and the Declaration of Human Rights (Helsinki, 1975 ). These individuals were deemed healthy after a review of their medical history, physical examination, and blood and urine analyses, in addition to magnetic resonance images of the brain. None of them was receiving any medication. The protocol of this study was approved by the Clinical Committee on Radioisotope Use of Tohoku University.
Protocol for PET Studies
The PET studies were performed using a 3D PET scanner with 32 ring detectors (model SET2400W; Shimadzu, Inc., Kyoto, Japan). Spatial resolution was 3.9 mm at full width at half maximum, and the axial field of view was 200 mm. 12 The participants lay comfortably on a scanner couch with their eyes closed in a quiet, dimly lit room. All medications were discontinued at least 9 hours before the PET scans were obtained. Transmission scanning was also performed for 10 minutes by using a 68 Ge/
68
Ga external rotating line source (370 MBqs at purchase) to correct the tissue attenuation of emission photons. Acquired data were reconstructed into 128 ϫ 128 ϫ 63-matrix images for a set of 3D volume images by applying a filtered 3D back-projection algorithm with the Tohoku University supercomputer (SX-4/128H4). 6 The 11 C-nemonapride was synthesized as described previously. 16 Radiochemical purity was more than 99% and the specific activity ranged from 250 mCi/mol to 1200 mCi/ mol at the end of the synthesis. The radiotracer was injected through a cannula placed in the antecubital vein. The 11 Cnemonapride, an average dose of 280 MBq in 3 to 5 ml of saline, was injected intravenously over a period of 60 seconds. The PET scanning was performed for 90 minutes starting 30 seconds after the administration of the ligand: six 60-second scans, eight 180-second scans, six 300-second scans, and three 600-second scans. Neither excessive agitation nor body movement was observed during the scanning period.
Evaluation of the Binding Potential of Dopamine Receptors
Seven hemispheres that underwent surgical intervention, five unilaterally and one bilaterally, and five hemispheres without intervention were subjected to the binding potential analysis. An ROI analysis was conducted using average 11 C-nemonapride-enhanced images obtained 70 to 90 minutes after injection of the tracer. As shown in Fig. 2 , in each hemisphere, ROIs were defined in the putamen, thalamus, dorsolateral prefrontal cortex (Brodmann areas 9 and 46) , ACC (Brodmann areas 24 and 32) , posterior cingulate cortex (Brodmann areas 23 and 31) , temporal cortex (Brodmann areas 21, 22, 37, and 38), and parietal cortex (Brodmann areas 7, 39, and 40). The positioning of ROIs was guided by findings on the magnetic resonance images of the patients and volunteers. The occipital cortex served as a reference region because little specific binding has been detected in this region. 23 The following equilibrium model was used for the assessment of the binding potential: binding potential = Cs/Cr Ϫ 1, where Cs and Cr were defined as the radioactivity in individual specific and reference regions.
Assessment of Clinical Correlation With D 2 Receptor Binding Potential
Changes in the Hoehn and Yahr stage, total UPDRS score, and motor (items 18-31) and dopa-induced dyskinesia (items 32 and 33) ly available software (StatView 5.0J; SAS Institute, Inc., Cary, NC). The comparison of Hoehn and Yahr stage, total UPDRS, and Schwab and England scores before and after the surgery was performed using the Student t-test, and a probability value of 0.05 or less was considered to be significant. The D 2 receptor binding potential in patients with PD was compared with that in normal volunteers by using analysis of variance with the Bonferroni post hoc comparison. A probability value of 0.0167 or less was considered significant. The D 2 receptor binding potential in the hemispheres in which no intervention was performed was compared before and after the surgery by using the MannWhitney U-test. A probability value of 0.05 or less was considered significant. To determine significant variables for the D 2 receptor binding potential, multivariate logistic regression was performed on ordinal data.
Results

Clinical Outcome
The patients' clinical symptoms were remarkably improved after the surgery. The Hoehn and Yahr stage was significantly lower in the off state (p Ͻ 0.05), and the Schwab and England score in the off state increased significantly (p Ͻ 0.05). The total UPDRS score was also improved in both on and off states (p Ͻ 0.01). The clinical outcome of the surgery is summarized in Table 2 .
Binding Potential of the Dopamine D 2 Receptor
Before the surgery, the D 2 receptor binding potential in the putamen of the patients (1.815 Ϯ 0.256; all values given in arbitrary units) was significantly higher than that in healthy volunteers (1.43 Ϯ 0.185, p Ͻ 0.01). On the other hand, the D 2 receptor binding potential in the thalamus (0.364 Ϯ 0.077) was significantly lower than that in healthy volunteers (0.513 Ϯ 0.067, p Ͻ 0.01). No significant difference was seen in other regions.
The D 2 receptor binding potential in the putamen and thalamus was returned to the level found in healthy volunteers after surgery (Fig. 3A and B) . In addition, the D 2 receptor binding potential in the ACC (0.067 Ϯ 0.054) was significantly lower than that in healthy volunteers (0.175 Ϯ 0.078, p Ͻ 0.01; Fig. 3C ). No significant postoperative changes were observed in other areas, and the postoperative changes in hemispheres with no intervention were not significant (data not shown).
Theoretically, the destruction by PVP and stimulation by DBS are expected to exert different effects on the motor control system, 9 and we compared the effect of the PVP and DBS on the D 2 receptor binding potential separately. In re- 
Correlation of Clinical Outcome With Binding Potential of the Dopamine D 2 Receptor
Because no apparent difference in the D 2 receptor binding potential was seen after the PVP and DBS, the results of PVP and DBS were combined in the comparison with clinical outcome. No correlation was seen between the D 2 receptor binding potential and the Hoehn and Yahr stage, total UPDRS score, motor and dopa-induced dyskinesia subscores of the UPDRS, and Schwab and England score in both the on and off states. There was a strong correlation, however, between percent improvement rates of total UPDRS scores in the off state and the percentage change of D 2 receptor binding potential in the putamen (Fig. 4 ; r = 0.773, p = 0.0417, Pearson linear correlation).
Discussion
Dopamine D 2 Receptor Binding Potential in the Putamen
Our study clearly showed that the D 2 receptor binding potential in the putamen of patients with advanced PD was significantly higher than that in healthy volunteers. The level of D 2 receptor binding potential in PD has been a matter of controversy. In some studies an elevation of D 2 receptor binding potential has been shown in the putamen, 3, 22, 42, 43 but in others contrary results have been reported. 4, 14, 35, 39 Moreover, in several studies it has been shown that the D 2 receptor binding potential was elevated in the early stage but not in the advanced stage. 1, 48, 50 The conflicting results might be partly due to the specificity of the tracer. In the past, 11 C-raclopride was commonly used but its binding specificity to the D 2 receptor is lower than that of 11 C-nemonapride. Nemonapride is a strong D 2 antagonist and its binding specificity to dopamine receptors is on the order of D 2 greater than D 3 greater than D 4 . 16 Thus, nemonapride can be expected to reflect the D 2 receptor binding potential more accurately than raclopride. The specificity of the ligand is crucial in this type of study because a 15% elevation of the D 2 receptor binding potential and a 40 to 45% reduction of the D 3 receptor binding potential are reported in the putamen of patients with advanced PD. 37 It is also noteworthy that the D 2 receptor binding potential is affected not only by the course of illness but also by various drugs, including levodopa, dopamine agonist, and monoamine oxidase-B inhibitor. 32, 45 One of the impressive findings in this study is the reversal of elevated D 2 receptor binding potential in the putamen after the surgery. The mechanism underlying this phenomenon is speculative. If the elevation of the D 2 receptor binding potential in the putamen in patients with advanced PD is compensatory for excessive inhibitory output from the GPi, the postoperative decline of the D 2 receptor binding potential in the putamen might be related to the reduction of an excessive inhibitory output from the GPi to the motor thalamus after the surgery. 26, 27 It would be accompanied by subsequent activation of the premotor and supplementary motor areas and amelioration of parkinsonism after PVP or DBS of the GPi.
5,28,40
Dopamine D 2 Receptor Binding Potential in the Thalamus
Before surgery, the D 2 receptor binding potential in the thalamus was lower than that in healthy volunteers. This observation is consistent with the report by Kaasinen, et al., 23 who showed that the binding potentials of the D 2 and D 3 receptors in the medial thalamus were decreased by 17% compared with those in healthy volunteers. They examined the medial and lateral thalamus separately, and found that the decline of the D 2 receptor binding potential had occurred only in the medial thalamus. Kaasinen, et al., also suggested that cognitive disorders and emotional deficits in PD might be related to the decline of the binding potential of D 2 and D 3 receptors in the medial thalamus. 46 Although Riordan, et al., 36 showed improvement in cognitive and emotional deficits after PVP or DBS of the GPi, others reported no changes in cognitive and emotional deficits after surgery. 8, 38, 47 In our study, items 1 to 4 of the UPDRS, reflecting mood and depression, did not change after the surgery despite normalization of the D 2 receptor binding potential in the thalamus. Because the D 2 receptor binding potential of the thalamus is lower than that of the putamen, and the function of binding potential in the thalamus is poorly understood, the implication of a reduced D 2 receptor binding potential in PD and normalization of the D 2 receptor binding potential after PVP and DBS of the GPi remains to be elucidated.
Dopamine D 2 Receptor Binding Potential in the ACC
Unlike the report by Kaasinen, et al., 23 the D 2 receptor binding potential in the ACC of our patients was not statistically different from that in healthy volunteers. This discrepancy might be attributable to the use of a different tracer. Kaasinen, et al., used FLB457, which is more useful for extrastriatal regions than nemonapride and raclopride. It is also possible that the clinical status of their patients was different from ours, but clinical details were not fully given in their paper.
The function of the ACC is not fully understood, but two functions are postulated. One is motor programming; 49 akinesia associated with mesial frontal lesions is often attributed to impairment of the supplementary motor area, but monkeys with a lesion confined to this area are not akinetic. Thus, Playford, et al., 33 suggested that additional involvement of the ACC was important in the genesis of akinesia. If this is the case, the postoperative reduction of the D 2 receptor binding potential in the ACC might be related to improvement in akinesia after pallidal surgery.
On the other hand, the reduction of the D 2 receptor binding potential in the ACC is thought to be responsible for the impairment of working memory after pallidal surgery, 25, 36, 38 because this area is activated during the performance of the Stroop color/word interference test 31 and of a task involving a semantic decision in word sorting. 34 
Correlation Between Clinical Outcome and Binding Potential of the Dopamine D 2 Receptor
In agreement with a previous report, 11 clinical improvement in this study was more remarkable in the off than in the on state. Although there was no correlation between the level of D 2 receptor binding potential in the putamen and individual parameters of clinical symptoms, the percentage change in the D 2 receptor binding potential was positively correlated with the percent improvement rate of total UPDRS scores in the off state. We found that PVP or DBS of the GPi were highly effective for dopa-induced dyskinesia (an improvement rate of Ն 80% was seen in contralateral dopa-induced dyskinesia). There was also an approximately 30% improvement in total motor scores; this improvement was accompanied by significant reductions in contralateral akinesia, rigidity, and tremor. 2, 9, 24, 26, 27, 29 Such an amelioration of motor activities may improve performance of activities of daily living and facilitate independence. 26, 27, 29 This could be the reason pallidal surgery improves not only the motor score but also the mood, activities of daily living, and dopa-induced dyskinesia scores on the UPDRS.
Although the number of cases is small, our results indicate a close association of the D 2 receptor binding potential with clinical symptoms in PD. Because an association of D 2 receptor gene polymorphisms with motor fluctuations in PD has been reported recently, 51 the D 2 receptor may well be intimately related to both the genesis and fluctuation of motor deficits in PD. Nevertheless, the functional relationship between dopamine receptors in the putamen and clinical symptoms remains elusive. 1, 4, 23, 39, 48, 50 In a PET investigation it has been demonstrated that the binding potential of the D 2 receptor is elevated in PD in earlier stages but returns to a control level in the advanced stage. 
Conclusions
Pallidal surgery alters the binding potential of dopamine D 2 receptors in the putamen and thalamus, and it is accompanied by the improvement of clinical symptoms in advanced PD.
